Analyst Ratings for Tarsus Pharmaceuticals (TARS)
TARS Rating Summary
TARS Price Target Summary
- Highest: $105.00 (Oppenheimer)
- Lowest: $87.00 (Guggenheim)
- Average: $96.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$96.00 (+31%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
Avg. $ Target:
$96.00 (+31%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/9/2025 | Barclays | Glen Santangelo | New Coverage | Overweight (N/A) |
100.00 (N/A) |
81.77 (73.26) |
-10.41% | Details |
| 11/20/2025 | Mizuho | Graig | New Coverage | Outperform (N/A) |
100.00 (N/A) |
77.11 (73.26) |
-4.99% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
